Related Experiment Video

Updated: Jun 7, 2026

A Fluorescence-based Exonuclease Assay to Characterize DmWRNexo, Orthologue of Human Progeroid WRN Exonuclease, and Its Application to Other Nucleases
06:10

A Fluorescence-based Exonuclease Assay to Characterize DmWRNexo, Orthologue of Human Progeroid WRN Exonuclease, and Its Application to Other Nucleases

Published on: December 23, 2013

Differential DNA damage response to WRN inhibition identifies a targetable vulnerability in ARID1A-mutated cancers

Jiwon Kim1, Jaeik Oh2, Dongjun Jang1

  • 1Department of Biomedical Sciences, Seoul National University College of Medicine, Seoul 03080, Republic of Korea.

Science Advances
|June 5, 2026
PubMed

Insights

Targeting WRN (Werner syndrome helicase) offers a new strategy for ARID1A-mutated cancers. Inhibiting WRN, alone or with p21, shows promise in preclinical models, providing hope for effective treatments.

Area of Science:

  • Cancer Biology
  • Genetics
  • Chromatin Remodeling

Background:

  • ARID1A mutations are common in various cancers, but effective treatments are lacking.
  • ARID1A is a crucial component of the SWI/SNF chromatin remodeling complex.
  • Identifying new therapeutic vulnerabilities in ARID1A-mutated cancers is critical.

Purpose of the Study:

  • To identify and validate therapeutic targets in ARID1A-mutated cancers.
  • To investigate the role of Werner syndrome adenosine 5'-triphosphate-dependent helicase (WRN) in ARID1A-mutated cancers.
  • To explore the potential of WRN inhibition as a treatment strategy.

Main Methods:

  • Genetic and pharmacological inhibition of WRN in cancer cell lines.
  • Analysis of DNA damage signaling pathways, including Chk1 and Chk2.
  • Assessment of cell cycle arrest and apoptosis induction.
  • Evaluation of combination therapy with p21 inhibition.
  • Validation in xenograft and patient-derived xenograft mouse models.

Main Results:

  • WRN inhibition selectively impairs DNA damage signaling and induces G1 arrest and apoptosis in ARID1A-mutated cells.
  • ARID1A-proficient cells exhibit Chk1-dependent G2-M arrest upon WRN inhibition.
  • Combined WRN and p21 inhibition enhances cytotoxicity in ARID1A-mutated cells via mitotic catastrophe.
  • WRN inhibition demonstrates antitumor efficacy in preclinical cancer models.

Conclusions:

  • WRN is a critical vulnerability and a selective therapeutic target in ARID1A-mutated cancers.
  • Combination therapy with WRN and p21 inhibitors presents a promising therapeutic approach.
  • These findings pave the way for novel treatment strategies for patients with ARID1A-mutated cancers.

More Related Videos

Genetic Studies of Human DNA Repair Proteins Using Yeast as a Model System14:09

Genetic Studies of Human DNA Repair Proteins Using Yeast as a Model System

Published on: March 18, 2010

Assessment of Global DNA Double-Strand End Resection using BrdU-DNA Labeling coupled with Cell Cycle Discrimination Imaging06:44

Assessment of Global DNA Double-Strand End Resection using BrdU-DNA Labeling coupled with Cell Cycle Discrimination Imaging

Published on: April 28, 2021

Related Concept Videos

Nucleotide Excision Repair01:38

Nucleotide Excision Repair

DNA Distortion and Damage
Cells are regularly exposed to mutagens—factors in the environment that can damage DNA and generate mutations. UV radiation is one of the most common mutagens and is estimated to introduce a significant number of changes in DNA. These include bends or kinks in the structure, which can block DNA replication or transcription. If these errors are not fixed, the damage can cause mutations, which in turn can result in cancer or disease depending on which sequences are...
Nucleotide Excision Repair01:08

Nucleotide Excision Repair

Overview
Other Unique Bacteria01:18

Other Unique Bacteria

Magnetic bacteria exhibit a directed movement called magnetotaxis, driven by structures called magnetosomes. These magnetosomes consist of chains of magnetic particles made of either magnetite (Fe₃O₄) or greigite (Fe₃S₄) and are organized in a linear conformation by a protein scaffold within invaginations of the cell membrane. The bacteria align along the north–south magnetic field lines, much like a compass needle. They are typically microaerophilic or anaerobic and are commonly found near the...
DNA Damage can Stall the Cell Cycle02:36

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
DNA Damage Can Stall the Cell Cycle02:36

DNA Damage Can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
Mismatch Repair01:20

Mismatch Repair

Organisms are capable of detecting and fixing nucleotide mismatches that occur during DNA replication. This sophisticated process requires identifying the new strand and replacing the erroneous bases with correct nucleotides. Mismatch repair is coordinated by many proteins in both prokaryotes and eukaryotes.
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...